Preclinical efficacy evaluation of the lipid-based smedds formulation of DIM, BR-9001, to award 3

Ended Awarded Last action

Contract number
75N91018F00003
Awardee
Awarding agency
Obligated
$970,988

Award facts

Opportunity
  • NO1CN500347 Solicitation number
Contract value 100% obligated
$970,988.47 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Chicago, IL 60616, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00005 -$2,943
Other Administrative Action P00004 · Based smedds formulation of DIM, BR-9001 $0
Other Administrative Action P00003 · The purpose of this modification is to a) extend the task order period of performance for an additional three-months at no cost to the government; B)… $0
Other Administrative Action P00002 $0
Exercise an Option P00001 · Exercise option 1PRECLINICAL efficacy evaluation of the lipid-based smedds formulation of DIM, BR-9001, $118,948
Original award $854,983

About this award

Written by GovTribe AI ·

This is a firm fixed price delivery order awarded by the National Cancer Institute, part of the Department of Health and Human Services National Institutes of Health, to IIT Research Institute. The order is for preclinical efficacy evaluation of a lipid-based SMEDDS formulation of the drug compound DIM, BR-9001, as part of the NCI's Preclinical Prevent Cancer Program. The $970,988.47 contract has a completion date of February 7, 2022. IIT Research Institute is a non-profit research organization and the research and technology development arm of Illinois Institute of Technology, a private university. No set-aside designation was used for this award. The contract is a delivery order under the NCI's PREVENT Cancer Program IDIQ vehicle, enabling the agency to leverage IIT Research Institute's drug testing capabilities in support of cancer prevention research on an as-needed basis.

Quick answers

Who was awarded contract 75N91018F00003?

75N91018F00003 was awarded to IIT Research Institute by National Cancer Institute (National Institutes of Health) on August 8, 2018.

How much is contract 75N91018F00003 worth?

The government has obligated $970,988 on 75N91018F00003.

Is contract 75N91018F00003 an order under another contract?

Yes. 75N91018F00003 is a delivery order under HHSN261201500042I, an indefinite delivery contract, on PREVENT Cancer Program (PREVENT).

Was contract 75N91018F00003 competed?

The extent of competition for 75N91018F00003 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login